Paper34831726
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.
Jakubiak GK and 3 others. Int J Environ Res Public Health, 2021. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes. Papers, record 34831726. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34831726
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Restenosis | Major topic |
| Diabetes Mellitus | Major topic |
| Peripheral Arterial Disease | Major topic |
| Constriction, Pathologic | |
| Humans | |
| Stents |
Source PubMed
References175
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30738868 | Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG. | Life Sci | 2019 | https://conductscience.org/library/papers/30738868 | PubMed |
| 2 | 34440796 | Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury. | Cells | 2021 | https://conductscience.org/library/papers/34440796 | PubMed |
| 3 | 27572953 | Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27572953 | PubMed |
| 4 | 11773915 | Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. | Am Heart J | 2002 | https://conductscience.org/library/papers/11773915 | PubMed |
| 5 | 33280239 | Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33280239 | PubMed |
| 6 | 22652908 | MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. | Circ Res | 2012 | https://conductscience.org/library/papers/22652908 | PubMed |
| 7 | 31789115 | ESVM Guideline on peripheral arterial disease. | Vasa | 2019 | https://conductscience.org/library/papers/31789115 | PubMed |
| 8 | 24452084 | The level of complement C3 is associated with the severity of atherosclerosis but not with arterial calcification in peripheral artery disease. | Int Angiol | 2014 | https://conductscience.org/library/papers/24452084 | PubMed |
| 9 | 32583853 | The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery. | Biosci Rep | 2020 | https://conductscience.org/library/papers/32583853 | PubMed |
| 10 | 19383735 | Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. | Eur Heart J | 2009 | https://conductscience.org/library/papers/19383735 | PubMed |
| 11 | 33222019 | Mechanisms of drug-eluting stent restenosis. | Cardiovasc Interv Ther | 2021 | https://conductscience.org/library/papers/33222019 | PubMed |
| 12 | 26185603 | Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. | World J Diabetes | 2015 | https://conductscience.org/library/papers/26185603 | PubMed |
| 13 | 32175074 | mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. | Cell Biosci | 2020 | https://conductscience.org/library/papers/32175074 | PubMed |
| 14 | 12243851 | The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis. | Int J Cardiol | 2002 | https://conductscience.org/library/papers/12243851 | PubMed |
| 15 | 34076894 | Neutrophil elastase promotes neointimal hyperplasia by targeting toll-like receptor 4 (TLR4)-NF-κB signalling. | Br J Pharmacol | 2021 | https://conductscience.org/library/papers/34076894 | PubMed |
| 16 | 24995885 | Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting. | Exp Mol Pathol | 2014 | https://conductscience.org/library/papers/24995885 | PubMed |
| 17 | 24630390 | Global estimates of diabetes prevalence for 2013 and projections for 2035. | Diabetes Res Clin Pract | 2014 | https://conductscience.org/library/papers/24630390 | PubMed |
| 18 | 9426044 | In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. | J Am Coll Cardiol | 1998 | https://conductscience.org/library/papers/9426044 | PubMed |
| 19 | 26399921 | Neoatherosclerosis From a Pathologist's Point of View. | Arterioscler Thromb Vasc Biol | 2015 | https://conductscience.org/library/papers/26399921 | PubMed |
| 20 | 27867580 | Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. | J Thorac Dis | 2016 | https://conductscience.org/library/papers/27867580 | PubMed |
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842095 | Contralateral-controlled thigh muscle biomarkers on CT angiography for prediction of 1-year restenosis after endovascular therapy for unilateral peripheral artery disease. | Insights Imaging | 2026 | https://conductscience.org/library/papers/42842095 | PubMed |
| 41978756 | Short-term changes in interleukin 10 following drug-eluting stent placement in stable angina patients: Influence of hypertension. | Glob Cardiol Sci Pract | 2026 | https://conductscience.org/library/papers/41978756 | PubMed |
| 41827923 | Inflammatory Prognostic Index: A Novel Predictor of In-Stent Restenosis Following Drug-Eluting Stent-Percutaneous Coronary Intervention. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41827923 | PubMed |
| 41751207 | Animal Models of Restenosis and Intimal Hyperplasia in Cardiovascular Percutaneous Interventions: A Narrative Review. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751207 | PubMed |
| 41602323 | Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41602323 | PubMed |
| 41598548 | Tooth Loss as a Predictor of Coronary Artery Disease Severity in Patients with Acute Myocardial Infarction: A Prospective Cross-Sectional Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41598548 | PubMed |
| 41234452 | Effect of the prognostic nutritional index on stent restenosis in patients with chronic coronary syndrome. | Turk J Med Sci | 2025 | https://conductscience.org/library/papers/41234452 | PubMed |
| 41143187 | Association between stent length and number and the risk of in-stent restenosis in patients after percutaneous coronary intervention: a systematic review and meta-analysis. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41143187 | PubMed |
| 40978996 | Retrospective Analysis of In-Stent Restenosis in Diabetic Patients. | Cureus | 2025 | https://conductscience.org/library/papers/40978996 | PubMed |
| 40943944 | The Role of VEGF in Intervention-Mediated Injuries: Neointimal Hyperplasia and In-Stent Restenosis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40943944 | PubMed |
| 40756596 | Research advances in the etiology of in-stent restenosis of coronary arteries. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40756596 | PubMed |
| 40732999 | The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. | Nutrients | 2025 | https://conductscience.org/library/papers/40732999 | PubMed |
| 40594463 | Predictors for quantitative flow ratio loss in patients with de novo coronary artery disease treated with drug-coated balloons. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594463 | PubMed |
| 40507717 | Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety. | J Clin Med | 2025 | https://conductscience.org/library/papers/40507717 | PubMed |
| 40507488 | Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term Outcome. | J Clin Med | 2025 | https://conductscience.org/library/papers/40507488 | PubMed |
| 40429346 | Renal and Safety Outcomes of SGLT2 Inhibitors in Patients with Type 2 Diabetes: A Nationwide Observational Cohort Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40429346 | PubMed |
| 40269200 | The relationship of glycosylated hemoglobin A1c and Apolipoprotein A‑1 ratio on short-term prognosis in STEMI patients following PCI: a retrospective study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40269200 | PubMed |
| 40197255 | Endovascular treatment of intracranial blood blister-like aneurysms with the Willis covered stent: a case series. | BMC Surg | 2025 | https://conductscience.org/library/papers/40197255 | PubMed |
| 40190878 | A Rare Case of ST-Elevation Myocardial Infarction (STEMI) in a Paced Rhythm Meeting Full Sgarbossa Criteria in a 61-Year-Old Male With Complex Percutaneous Coronary Intervention and Post-Infarction Management Challenges. | Cureus | 2025 | https://conductscience.org/library/papers/40190878 | PubMed |
| 40045508 | Impact of Diabetes on Long-Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions. | Catheter Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/40045508 | PubMed |
Genes71
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34831726
GET https://conductscience.org/api/papers/v1/34831726/references?page=2